Sep 21, 2018 - Sutro Biopharma intends to raise at least $75 million from the sale of its common stock in a U.S. IPO.The firm is advancing a pipeline of protein therapeutics for various forms of cancer.STRO has rece
Sep 20, 2018 - Arvinas Holding aims to sell $100 million of its common stock in a U.S. IPO.The firm is advancing a pipeline of drug candidates for the treatment of various cancers.Although still a very early stage c
Sep 19, 2018 - Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $19.6 million of Shares, Stocks: MRK, release date:Sep 19, 2018
Sep 19, 2018 - Johnson & Johnson (JNJ) submits regulatory application to the FDA seeking approval of pan-FGFR inhibitor, erdafitinib, for the treatment of metastatic urothelial cancer, a type of bladder cancer.
Sep 18, 2018 - Accenture's (ACN) latest partnership is likely to boost its Products segment.
Sep 18, 2018 - Pfizer's (PFE) latest anti-PD-L1 immunotherapy, Bavencio, is being touted as a significant long-term top-line driver for the company.
Sep 15, 2018 - FibroGen's pamrevlumab fast tracked for IPF.Dr. Reddy’s generic launch.Bristol-Myers Squibb succeeds in mid-stage trials.
Sep 14, 2018 - Investors need to pay close attention to Merck (MRK) stock based on the movements in the options market lately.
Sep 14, 2018 - Merck's application for first-line pembrolizumab in a wider patient population has now been accepted.If approved, it could change the dimension of the market for non-small cell lung cancer.What does t
Sep 14, 2018 - Label expansion of Merck's (MRK) Keytruda and FDA approval of AstraZeneca's (AZN) leukemia drug grab headlines this week